BioSpace News Archive

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of an underwritten registered offering of 15,790,000 shares of its common stock, par value $0.001 per share (“Common Stock”), offered at a price of $28.50 per share, before underwriting discounts.

PureTech Health plc announced that Daphne Zohar, Founder and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:00 a.m. PST / 12:00 p.m. EST.

ABVC BioPharma, Inc. and its subsidiary BioLite, Inc. announced that the Company and its subsidiary received an aggregate of 46 million shares from AiBtl BioPharma Inc., as its first milestone payment under a global licensing agreement.

Elektrofi, Inc. announced that it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.

Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D.

Scribe Therapeutics Inc. announced that Sanofi has exercised its option for a second target as part of the companies’ research collaboration to develop in vivo CRISPR-based therapeutics.

Melt Pharmaceuticals, Inc., a clinical‑stage pharmaceutical company developing novel approaches for procedural sedation, provided a corporate update.

Radionetics Oncology, Inc. announces the completion of a $52.5 million Series A financing.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.

LumiThera Inc. announced an update on the regulatory status of the Valeda® Light Delivery System.